...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Updates
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Hartland

I am not quite sure where the trial commencement stands. The Zenith website states -

Phase 1 is expected to commence in the first half of 2016

Sarah's comment to BDAZ implies that the trial has not yet started but is the top priority

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply